Halozyme Therapeutics, Inc.

The momentum for this stock is not very good. Halozyme Therapeutics, Inc. is not very popular among insiders. Halozyme Therapeutics, Inc. is a mediocre stock to choose.
Log in to see more information.
Halozyme Therapeutics, Inc. is a biopharmaceutical company, which engages in research, development &...

News

Halozyme Therapeutics, Inc. (NASDAQ:HALO) Shares Bought by Texas Permanent School Fund Corp
Halozyme Therapeutics, Inc. (NASDAQ:HALO) Shares Bought by Texas Permanent School Fund Corp

Zolmax Texas Permanent School Fund Corp lifted its position in shares of Halozyme Therapeutics, Inc. (NASDAQ:HALO - Free Report) by 6.0% during the 2nd quarter, according to the company in its most recent...\n more…

Arizona State Retirement System Lowers Position in Halozyme Therapeutics, Inc. (NASDAQ:HALO)
Arizona State Retirement System Lowers Position in Halozyme Therapeutics, Inc. (NASDAQ:HALO)

Ticker Report Arizona State Retirement System decreased its position in Halozyme Therapeutics, Inc. (NASDAQ:HALO - Free Report) by 2.0% in the 2nd quarter, according to the company in its most recent 13F filing...\n more…

Arizona State Retirement System Sells 735 Shares of Halozyme Therapeutics, Inc. (NASDAQ:HALO)
Arizona State Retirement System Sells 735 Shares of Halozyme Therapeutics, Inc. (NASDAQ:HALO)

Zolmax Arizona State Retirement System trimmed its stake in Halozyme Therapeutics, Inc. (NASDAQ:HALO - Free Report) by 2.0% during the 2nd quarter, Holdings Channel reports. The firm owned 35,569 shares of...\n more…

LSV Asset Management Has $32.14 Million Stake in Halozyme Therapeutics, Inc. (NASDAQ:HALO)
LSV Asset Management Has $32.14 Million Stake in Halozyme Therapeutics, Inc. (NASDAQ:HALO)

Ticker Report LSV Asset Management increased its position in Halozyme Therapeutics, Inc. (NASDAQ:HALO - Free Report) by 32.9% in the second quarter, according to its most recent 13F filing with the SEC. The firm...\n more…

Great Lakes Advisors LLC Decreases Stock Holdings in Halozyme Therapeutics, Inc. (NASDAQ:HALO)
Great Lakes Advisors LLC Decreases Stock Holdings in Halozyme Therapeutics, Inc. (NASDAQ:HALO)

Ticker Report Great Lakes Advisors LLC lessened its holdings in Halozyme Therapeutics, Inc. (NASDAQ:HALO - Free Report) by 7.4% during the second quarter, according to the company in its most recent filing with...\n more…

Halozyme Therapeutics, Inc. (NASDAQ:HALO) Receives Average Rating of "Moderate Buy" from Brokerages
Halozyme Therapeutics, Inc. (NASDAQ:HALO) Receives Average Rating of "Moderate Buy" from Brokerages

Zolmax Shares of Halozyme Therapeutics, Inc. (NASDAQ:HALO - Get Free Report) have been given a consensus rating of "Moderate Buy" by the nine brokerages that are covering the firm, Marketbeat.com reports...\n more…